ロード中...
Advancing Trial Design in Progressive Multiple Sclerosis
The failure of a majority of clinical trials in progressive MS has highlighted the need to reconsider how these trials are designed and conducted, and many areas deserve focus. Basic scientists are reconceptualising the pathophysiology of progressive MS into three broad areas: systemic inflammation,...
保存先:
| 出版年: | Mult Scler |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5714314/ https://ncbi.nlm.nih.gov/pubmed/29041871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517729768 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|